» Articles » PMID: 11715067

A Novel Mitochondrial DNA Mutation and a Mutation in the Notch3 Gene in a Patient with Myopathy and CADASIL

Overview
Specialty General Medicine
Date 2001 Nov 21
PMID 11715067
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is characterized by cerebral symptoms, but peripheral nerve or muscle involvement has not been reported. We describe a patient who had a stereotypic clinical presentation of CADASIL and, in addition, myopathy with ragged-red fibers, suggesting a mitochondrial disorder. Therefore we determined the nucleotide sequence in the entire coding region of the patient's mtDNA by conformation-sensitive gel electrophoresis and sequencing. Sequence of the exon 4 in the Notch3 gene was determined in a similar fashion. We found that the patient had myopathy with ragged-red fibers, and ultrastructural examination revealed mitochondrial aberrations. CADASIL was due to an R133C mutation in Notch3; in addition, we found a novel mutation 5650G>A in the tRNAAla gene in mtDNA. The mutation was heteroplasmic, with the proportions of the mutant genome being 99% in muscle, 96% in the buccal epithelium, 95% in the skin, and 65% in the blood. The absence of the mutation in a maternal cousin four times removed indicated that it was new in the pedigree. We suggest that the mtDNA mutation is pathogenic, as it was associated with a relevant clinical phenotype, it was not found among controls, and it altered a structurally important segment in the amino acid acceptor stem in the tRNAAla. Furthermore, its absence in nine patients from five families with R133C suggests that its relationship with the Notch3 mutation is coincidental.

Citing Articles

Mitochondrial base editing: from principle, optimization to application.

Tang J, Du K Cell Biosci. 2025; 15(1):9.

PMID: 39856740 PMC: 11762502. DOI: 10.1186/s13578-025-01351-8.


mitoTALEN reduces the mutant mtDNA load in neurons.

Bacman S, Barrera-Paez J, Pinto M, Van Booven D, Stewart J, Griswold A Mol Ther Nucleic Acids. 2024; 35(1):102132.

PMID: 38404505 PMC: 10883830. DOI: 10.1016/j.omtn.2024.102132.


High-throughput single-cell analysis reveals progressive mitochondrial DNA mosaicism throughout life.

Glynos A, Bozhilova L, Frison M, Burr S, Stewart J, Chinnery P Sci Adv. 2023; 9(43):eadi4038.

PMID: 37878704 PMC: 10599618. DOI: 10.1126/sciadv.adi4038.


Mitochondrial DNA heteroplasmy is modulated during oocyte development propagating mutation transmission.

Zhang H, Esposito M, Pezet M, Aryaman J, Wei W, Klimm F Sci Adv. 2021; 7(50):eabi5657.

PMID: 34878831 PMC: 8654302. DOI: 10.1126/sciadv.abi5657.


Ancient mitochondrial DNA pathogenic variants putatively associated with mitochondrial disease.

Toncheva D, Serbezov D, Karachanak-Yankova S, Nesheva D PLoS One. 2020; 15(9):e0233666.

PMID: 32970680 PMC: 7514063. DOI: 10.1371/journal.pone.0233666.